It has faced intense competition from Eli Lilly’s rival weight loss jab Mounjaro, as well as what it blasted as “unsafe and ...

Novo Nordisk stock took a big hit early Tuesday after the Danish weight-loss drugmaker unexpectedly cut its full-year guidance for the U.S.It also announced a new CEO, appointing an insider to lead ...